Role of circular RNA in neurological disease

Role of circular RNA in neurological disease

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Dettagli Bibliografici
Autore principale:	Salsabil, Labiba
Altri autori:	Chowdhury, Namara Mariam
Natura:	Tesi
Lingua:	English
Pubblicazione:	Brac University 2024
Soggetti:	Circular RNA circRNA Neurological disorder Alzheimer’s disease Parkinson’s disease Nervous system > Diseases. Molecular neurobiology.
Accesso online:	http://hdl.handle.net/10361/23932

Documenti analoghi

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
di: Dey, Manashi
Pubblicazione: (2024)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
di: Halim, Rabea
Pubblicazione: (2022)

Potential treatments for epigenetic dysregulation in neurological diseases
di: Zaman, Rubaiyat
Pubblicazione: (2024)

Targeting circular RNA for cardiovascular diseases
di: Sarkar, Deepannita
Pubblicazione: (2023)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
di: Bakar, Osama Bin Abu
Pubblicazione: (2024)

RNA drugs and RNA targets for small molecules: Prospects and challenges
di: Islam, Md. Raihanul
Pubblicazione: (2024)

Implications of unusual non-coding RNAs in human diseases
di: Ahmed, Tazkia
Pubblicazione: (2021)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
di: Mostofa, Golam
Pubblicazione: (2022)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
di: Chowdhury, Sariya Uzrat
Pubblicazione: (2022)

A review on optogenetics and its potential in neurological disorder management
di: Armin, Fariza
Pubblicazione: (2024)

A computational approach to design putative potential siRNAs for silencing the nucleoprotein and surface glycoprotein gene of MARV
di: Suraiya, Tasnia Iffat
Pubblicazione: (2023)

Gene editing for neurodegenerative diseases-A review
di: Sharna, Anika Islam
Pubblicazione: (2023)

Diagnostic biomarkers of Parkinson’s disease: The present and the future
di: Ferdous, Labiba
Pubblicazione: (2023)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
di: Alim, Abdul
Pubblicazione: (2023)

Impact of Lifestyle on the Disease Progression of Parkinson’s
di: Annee, Israt Jahan
Pubblicazione: (2023)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
di: Tasneem, Sadia
Pubblicazione: (2021)

A review paper on developing novel antiviral strategies against pathogenic RNA viruses
di: Nawar, Numia
Pubblicazione: (2021)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
di: Tabassum, Nadira
Pubblicazione: (2024)

Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
di: Afsana, Nourin
Pubblicazione: (2022)

Role of protein’s and future treatment options for Alzheimer’s Disease
di: Islam, Md. Irfath
Pubblicazione: (2023)

Unlocking the therapeutic potential of RNA: a comprehensive review of RNA-based therapy
di: Ahmad, Rafid Uddin, et al.
Pubblicazione: (2024)

Role of voltage-gated sodium channel modulators in peripheral nervous system disorders
di: Mithila, Sabekun Nahar
Pubblicazione: (2023)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
di: Shehab, Habibul Mohsin
Pubblicazione: (2024)

A review on RNAi technology and its therapeutic potential in Cancer
di: Mahaleka, Aarshi
Pubblicazione: (2024)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
di: Aziz, Farhin
Pubblicazione: (2019)

A look into parkinson’s disease and the implications of gene therapy as a novel clinical approach
di: Islam, Md. Rakibul
Pubblicazione: (2023)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
di: Karmaker, Swastika
Pubblicazione: (2024)

Therapeutic implication of senescent cell elimination in neurodegenerative diseases
di: Key, Nasrin Sultana
Pubblicazione: (2023)

Cerebrovascular and neurological dysfunction as a result of COVID-19 infection in patients with migraine
di: Rawshan, A. E. Maisha
Pubblicazione: (2022)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
di: Ishrat, Nowshin
Pubblicazione: (2024)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
di: Saha, Bithi Rani
Pubblicazione: (2023)

Parkinson's disease in Bangladesh: An evaluation of the public knowledge and awareness
di: Chowdhury, Amal
Pubblicazione: (2024)

Treatment options of Parkinson’s disease: How far we are from the cure?
di: Afreen, Nuraia
Pubblicazione: (2021)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
di: Hassan, Md. Muhtaz
Pubblicazione: (2020)

A review on the role of Myc and miRNA in Glioblastoma multiforme
di: Naureen, Ishrat
Pubblicazione: (2022)

Review on: the mechanism and function of Glia in parkinson's disease
di: Abedin, Khondokar Mezbahul
Pubblicazione: (2023)

Alzheimer's disease and marriage : an intimate account /
di: Wright, Lore K.
Pubblicazione: (1993)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
di: Tamanna, Mst. Taskia
Pubblicazione: (2023)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
di: Nuha, Nabiha Tahsin
Pubblicazione: (2024)

Detection of Parkinson’s disease from Neuro-imagery using deep neural network with transfer learning
di: Asaduzzaman, et al.
Pubblicazione: (2021)